Skip to main content
The Canadian Veterinary Journal logoLink to The Canadian Veterinary Journal
. 1987 Nov;28(11):693–695.

Equine Viral Arteritis

Peter J Timoney, William H McCollum
PMCID: PMC1680490  PMID: 17422919

Abstract

Equine viral arteritis is reviewed with specific reference to clinical features, etiology, transmission, diagnosis, epidemiology, and current methods for the control of this disease. There is evidence of variation in pathogenicity among strains of equine arteritis virus. Virus transmission occurs primarily by the respiratory and venereal routes during the acute phase of the infection. The long-term carrier stallion appears to play a major epidemiological role in dissemination and perpetuation of the virus. Unlike the stallion, the carrier state has yet to be demonstrated in the mare or foal. A commercial modifiedlive equine arteritis virus vaccine has been shown to be safe and efficacious for stallions and mares. The disease can be controlled by identification and isolation of carrier stallions, immunization of seronegative stallions, and by restricting the breeding of equine arteritis virus-shedding stallions to equine arteritis virus vaccinated or seropositive mares.

Full text

PDF
693

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRYANS J. T., CROWE M. E., DOLL E. R., MCCOLLUM W. H. Isolation of a filterable agent causing arteritis of horses and abortion by mares; its differentiation from the equine abortion (influenza) virus. Cornell Vet. 1957 Jan;47(1):3–41. [PubMed] [Google Scholar]
  2. Berry R. W., Arch S. Activation of neurosecretory cells enhances their synthesis of secretory protein. Brain Res. 1981 Jun 29;215(1-2):115–123. doi: 10.1016/0006-8993(81)90495-9. [DOI] [PubMed] [Google Scholar]
  3. Doll E. R., Bryans J. T., Wilson J. C., McCollum W. H. Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. Cornell Vet. 1968 Oct;48(4):497–524. [PubMed] [Google Scholar]
  4. Fukunaga Y., McCollum W. H. Complement-fixation reactions in equine viral arteritis. Am J Vet Res. 1977 Dec;38(12):2043–2046. [PubMed] [Google Scholar]
  5. McCollum W. H. Development of a modified virus strain and vaccine for equine viral arteritis. J Am Vet Med Assoc. 1969 Jul 15;155(2):318–322. [PubMed] [Google Scholar]
  6. McCollum W. H., Prickett M. E., Bryans J. T. Temporal distribution of equine arteritis virus in respiratory mucosa, tissues and body fluids of horses infected by inhalation. Res Vet Sci. 1971 Sep;12(5):459–464. [PubMed] [Google Scholar]
  7. Timoney P. J., McCollum W. H., Roberts A. W., McDonald M. J. Status of equine viral arteritis in Kentucky for 1986. Vet Rec. 1987 Mar 21;120(12):282–282. doi: 10.1136/vr.120.12.282. [DOI] [PubMed] [Google Scholar]
  8. Timoney P. J., McCollum W. H., Roberts A. W., McDonald M. J. Status of equine viral arteritis in Kentucky, 1985. J Am Vet Med Assoc. 1987 Jul 1;191(1):36–39. [PubMed] [Google Scholar]
  9. Timoney P. J., McCollum W. H., Roberts A. W., Murphy T. W. Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. Res Vet Sci. 1986 Sep;41(2):279–280. [PubMed] [Google Scholar]
  10. Westaway E. G., Brinton M. A., Gaidamovich SYa, Horzinek M. C., Igarashi A., Käriäinen L., Lvov D. K., Porterfield J. S., Russell P. K., Trent D. W. Togaviridae. Intervirology. 1985;24(3):125–139. doi: 10.1159/000149632. [DOI] [PubMed] [Google Scholar]

Articles from The Canadian Veterinary Journal are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES